IBM, AMD, Novo Nordisk Lead Midday Market Movers
Tech, retail, and healthcare stocks drive volatility as investors react to earnings and AI trends Several major stocks posted notable ...
Tag: NVO
FDA Flags Novo Nordisk’s Wegovy Pill Ad for Misleading Claims
Regulatory scrutiny adds pressure as competition intensifies in the booming GLP-1 market Food and Drug Administration has issued a warning ...
Eli Lilly and Novo Nordisk Strike Weight-Loss Drug Deal with Trump Administration
Landmark agreement cuts drug prices, expands Medicare access, and grants tariff relief to leading obesity drugmakers Eli Lilly & Co. ...
Pfizer, Novo Nordisk Eye Metsera; Sarepta Sinks, Hertz Surges
Tuesday’s trading session saw major pharmaceutical deals, biotech setbacks, and a surprise comeback in the car rental sector. On Tuesday’s ...
Novo Nordisk’s CagriSema Trial Results Shake Market Confidence
Disappointing Data Spurs $125 Billion Market Value Drop Novo Nordisk’s (NVO) ambitions in the competitive obesity drug market took a ...
